Evidence clearly refutes the claim that antiviral drugs remain effective when started after a shingles outbreak; clinical guidelines consistently emphasize that antivirals must be initiated within 72 hours of symptom onset to effectively reduce complications and pain.
The retrieved literature uniformly emphasizes that antiviral therapy for shingles (herpes zoster) must be initiated early—typically within 72 hours of rash onset—to be effective in reducing acute pain, lesion severity, and the risk of post-herpetic neuralgia or other complications. Studies that track treatment delays (such as papers [2], [8], and [10]) explicitly identify starting treatment after this window as a risk factor for poor outcomes, directly refuting the claim that they remain effective when started late.